BIO Patient and Health Advocacy Summit: Schedule

  • Recommend
  • Tweet
  • Print
  • Email

Renaissance Mayflower Hotel
1127 Connecticut Avenue NW
Washington, DC 20036


BIO Patient and Health Advocacy Summit:
The Power of Partnerships

October 8, 2013



Confirmed Speakers        

12:30 – 2:00 PM


Opening lunch/keynote


John F. Crowley, J.D., M.BA, Chairman and CEO, Amicus Therapeutics, Inc.

2:00 – 2:15 PM



2:15 - 3:30 PM


The Legislative Landscape: What to Expect in 2013 and Beyond


Moderator: Congressman Mike Ferguson, Chairman and CEO, Ferguson Strategies LLC
  • Charlotte Ivancic, Assistant to the Speaker for Policy, Speaker of the House John Boehner
  • Kate Leone, Senior Health Counsel, Senate Majority Leader Harry Reid
  • Emily K. Shetty, Senior Director, Legislative Affairs, Leukemia & Lymphoma Society
  •  Linda Tarplin, Tarplin, Downs & Young, LLC


3:30 – 3:45 PM



3:45-5:00 PM


One Week In: A Look at Enrollment, Coverage and Access in the New Health Insurance Exchanges


Moderator: Fritz Bittenbender, Senior Vice President, External Affairs, BIO
  • Crystal Kuntz, Vice President, Policy and Regulatory Affairs, America's Health Insurance Plans (AHIP)
  • Sally Baker McCarty, M.A., Senior Research Fellow, Center on Health Insurance Reform, Georgetown University Health Policy Institute
  • Alpha Lillstrom, Senior Director, Cancer Policy Institute at Cancer Support Community
  • Michelle Rice, Director of Policy, National Hemophilia Foundation

6:00 – 8:00 PM

Networking Reception

LINCOLN Restaurant

1110 Vermont Ave. NW




October 9, 2013



Confirmed Speakers

7:00 – 8:15 AM





8:15 – 8:30 AM

Welcome remarks


8:30 – 9:45 AM


Defining Patient-Focused Drug Development: Engaging the FDA


Moderator: Andrew W. Womack, Ph.D., Director, Science and Regulatory Affairs, BIO
  • Marc Boutin, Executive Vice President and Chief Operating Officer, National Health Council
  • Annie Kennedy, Senior Vice President, Advocacy, Muscular Dystrophy Association
  • Kimberly McCleary, Principal, kmc2 consulting, LLS
  • Theresa Mullin, PhD, Director, Office of Strategic Programs, FDA Center for Drug Evaluation & Research

9:45 – 10:00 AM





10:00 – 11:15 AM


Realizing Patient-Focused Drug Development: Embracing the Voice of the Patient

Moderator: Thomas A. Krohn, RPh, MBA, Advisor, Clinical Open Innovation, Eli Lilly and Company
  •  April S. Abernethy, N.D., Associate Director, Medical Programs, National Psoriasis Foundation
  • Lily Cappelletti, Associate Director, Reserach Partnerships, Michael J. Fox Foundation 
  • Sonali Chopra, Associate Director, Advocacy Relations, Genentech, Inc.

11:15 – 11:30 AM





11:30 – 1:00 PM


Enabling Patient-Focused Drug Development: Investing in Innovation


Moderator: Cecilia O. Arradaza, Director, Communications & Policy, FasterCures
  • Scott Johnson, President, CEO and Founder, Myelin Repair Foundation
  • Gail Maderis, President & CEO, BayBio
  • Debra Miller, Founder, CureDuchenne
  • John Richert, M.D., Vice President, MS Franchise for Global Medical Affairs, Biogen Idec
  • Hans GCP Schikan, Pharm.D., Chief Executive Officer, Prosensa